| Acyl-CoA | acyl-coenzyme A |
| AE | adverse event |
| ALA | alpha-lipoic acid |
| ATP | adenosine triphosphate |
| BBB | blood-brain barrier |
| BMI | body mass index |
| CGI | Clinical Global Impressions |
| CGI-S | Clinical Global Impressions-Severity of Illness |
| CI | confidence interval |
| CNS | central nervous system |
| COMT | catechol-O-methyltransferase |
| CoQ10 | coenzyme Q10 |
| CRP | C-reactive protein |
| DAG | diacylglycerol |
| DHLA | dihydrolipoic acid |
| EPA | eicosapentaenoic acid |
| HAM-D | Hamilton Depression Rating Scale |
| HPA | hypothalamic-pituitary-adrenal |
| HR | hazard ratio |
| hsCRP | high-sensitivity C-reactive protein |
| IL-8 | interleukin-8 |
| IP3 | inositol triphosphate |
| LAC | L-acetylcarnitine |
| LCFA | long chain fatty acids |
| MADRS | Montgomery–Åsberg Depression Rating Scale |
| MAOIs | monoamine oxidase inhibitors |
| MAPK | mitogen activated protein kinase |
| MDD | major depressive disorder |
| mGlu 2 | type 2 metabotropic glutamate |
| mGlu | metabotropic glutamate |
| MMA | methylmalonic acid |
| MTHF | L-5-methyl-tetrahydrofolate |
| MTHFR | 5,10-methylenetetrahydrofolate reductase |
| NAC | N-acetylcysteine |
| NMDA | N-methyl-D-aspartate |
| OR | odds ratio |
| PIP | phosphatidylinositol |
| PUFAs | polyunsaturated fatty acids |
| RR | relative risk |
| SAH | S-adenosylhomocysteine |
| SAMe | S-adenosylmethionine |
| SD | standard deviation |
| SMD | standardized mean difference |
| SNRIs | serotonin norepinephrine reuptake inhibitors |
| SSRIs | selective serotonin reuptake inhibitors |
| STAR*D | Sequenced Treatment Alternatives to Relieve Depression |
| TCAs | tricyclic antidepressants |
| TDO | tryptophan 2,3-dioxygenase |
| TNF-α | tumor necrosis factor-α |
| VDRs | vitamin D receptors |